Pankind

Federal Budget wins for pancreatic cancer: 🟣@OmicoAustralia’s PrOSPeCT program funded through 2028 🟣Renewed investment in the National One Stop Shop to speed up trial access Faster trial access can mean more time. Pankind will keep pushing for hope. Read CEO statement on LI

A new pancreatic cancer blood test has launched in Australia. Encouraging early signals, but it’s best viewed as an additional option while research continues. MRI + EUS remain gold standard for high-risk surveillance. Read more: ow.ly/3t0R50XZUBo

Today is World Pancreatic Cancer Day 📣 The time to act is now! Know the signs, act early and help spread awareness. @worldpcc 💜 Share this message 💜 Start a conversation 🔗 pankind.org.au/news/november-… #WPCD #HelloPancreas #EarlyDetectionMatters

After losing both his father and uncle to pancreatic cancer, Dr Will McGahan chose to expand his impact. We’re proud to award Dr McGahan The Marianne Allan Pancreatic Cancer Research Grant as part of Pankind’s 2025 Grant Program. 🔗pankind.org.au/research-proje…

November is Pancreatic Cancer Awareness Month! Pancreatic cancer often stays silent until it’s too late, knowing the signs can save lives. Don’t ignore these subtle symptoms, early action matters. Share to help spread awareness💜 @worldpancreatic 🔗 pankind.org.au/news/november-…

Remember September 2025! Together, we’ve raised $2,677,185 to advance pancreatic cancer research and improve outcomes for people affected by this disease. Shortly, we will be announcing the recipients of our 2025 Grants, made possible through movements like Remember September.

In a recent feature by Natasha Robinson for The Australian, the APRISE Study was brought into focus: the first national screening program for people with an increased familial or genetic risk of pancreatic cancer. 🔗 pankind.org.au/news/hope-rise…

When pancreatic cancer treatment options were limited, Dee began a Phase 1 KRAS G12D clinical trial at The Kinghorn Cancer Centre. Watch Dee's story of hope amidst Australia's toughest cancer. Full article available here👉 pankind.org.au/stories/dee-s-…

Can a colorectal cancer drug help treat Australia’s deadliest common cancer? NP137 is now being tested in pancreatic cancer labs. It targets both cancer cells and their environment, a key factor in this disease. Pankind CEO spoke to @7NewsMelbourne about the urgency of this.

Pankind are Telstra Best of Business Award Finalists and it’s all thanks to you 🎉 We’re proud to share that we have been named a Finalist in the 2025 Telstra Best of Business Awards, recognised in the Community Building category 💜 #TelstraBestofBusinessAwards

2025 Pankind Scientific Meeting Speakers & Program Announced 🔬 We are excited to bring together some of the brightest minds in research to join us at the only Australian meeting dedicated to pancreatic cancer. Register and learn more here: eventcreate.com/e/2025-pankind…

Amber Johns, our Head of Research and Programs, has been named @CharlesSturtUni's Alumnus of the Year 👏 Her work spans science, policy and care - driving progress where it’s most needed in pancreatic cancer. Thank you, Amber. We’re proud to have you leading this work.

$1 MILLION RAISED! 💜 Over 6000 of you have come together for #RememberSeptember, raising over $1M so far for pancreatic cancer research 👏 This is just the beginning, let’s fight until the finish. Join us today: rememberseptember.org.au

Today is the first #InheritedCancerAwarenessDay, not because these cancers are rare, but because awareness still is. 10% of pancreatic cancer cases are linked to inherited changes. Check your family’s risk today 👇 familychecker.pankind.org.au #pancreaticcancer #inheritedcancers

Remember September 💜 Honour those we’ve lost and stand with those facing pancreatic cancer. Join our challenge to help fund vital research, advocacy and support services. 🚶 Walk 75km (Move It) 🚫 Quit a vice (Give It Up) 🔗 rememberseptember.org.au #RememberSeptember #Pankind

Pankind Grant applications close 28 July 2025! Grants available for bold research in early detection + new treatments for pancreatic cancer. 🔬 Early Detection – $100K 💡 Innovation – $100K 🚀 Accelerator – $300K (2 yrs) 🔗 ow.ly/b0Nk50Wql6X #PancreaticCancer #Grants

Genomics Australia is live! 🧬 We're delighted Genomics Australia will lead the integration of genomics into Australia’s health system. Congratulations to Tiffany Boughtwood, Australia’s first Health Genomics Commissioner! 🔗 ow.ly/53XU50Wk8Bu #GenomicsAustralia #Pankind

A rare and hopeful result in #PancreaticCancer In @AmpliaTx’s ACCENT trial based on Pankind-funded research at @GarvanInstitute one patient had no cancer found after surgery (pathological complete response). 🔬 pankind.org.au/research-proje… 🔎 pankind.org.au/living-with-pa…

An Australian study confirms that distress remains high for people affected by pancreatic cancer, even within palliative care. Appetite changes, pain and emotional needs were most common, highlighting the need for better, more holistic support. 🔗 link.springer.com/article/10.100…

Rob Hirst, @midnightoilband drummer, recently spoke to The Australian about his pancreatic cancer diagnosis and the personal weight of a disease that continues to affect so many families. Full interview: theaustralian.com.au/nation/facing-… #midnightoil #pancreaticcancer #robhirst